The chart is self-explanatory! Price to earnings getting very low, company is solid and should see a bounce sooner or later at major support levels.
A nice triangle at the end of a long way down. Even though we did not face the ultimate action, the chances are the stage is set for upside. The best case is to see the short-lived break down but the solo break up is valid as well.
Focused on hemoderivatives (blood plasma), Grifols is great value by most of investors. Even though the company might be one day spitted by any scandal on how it is gathering the plasma in the US, americans have got a high stake on it and today it is focusing on an hyperimmune immunoglobulin with specific antibodies against the SARS-CoV-2 virus. Grifols estimated...
I think in this covid19 scenario grifols is a really good pic with the medical improvements that they are offering. It's a safe pick so i recommend reading about this coorporation and make your own research.